Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multicenter Study.

Natsu Otowa-SuematsuKazuhiko SakaguchiTomoaki NakamuraKenta HaraMinoru KishiNaoko HashimotoKazuki YokotaHiroshi YoshinoYasuo KurokiTomoko NishiumiAnna SouHisako KomadaYuko OkadaYushi HirotaYoshikazu TamoriWataru Ogawa

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2018)

This trial has been registered with UMIN (No. 000010769).

Keyphrases

combination therapy
open label
phase iii
phase ii
study protocol
clinical trial
type diabetes
phase ii study
randomized controlled trial
squamous cell carcinoma
insulin resistance
radiation therapy
weight loss